Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

3481. Optimal cost-effective timing of cranial ultrasound screening in low-birth-weight infants

Optimal cost-effective timing of cranial ultrasound screening in low-birth-weight infants Optimal cost-effective timing of cranial ultrasound screening in low-birth-weight infants Optimal cost-effective timing of cranial ultrasound screening in low-birth-weight infants Boal D K, Watterberg K L, Miles S, Gifford K L Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Cranial ultrasound screening at 2 weeks of age (on day of life 10-14) in low-birth-weight infants (intervention) versuscranial ultrasound screening beginning in the first week of life and carried out in two stages involving ultrasound examinations on day of life (DOL) 4 or 5 and DOL 14 (comparator) for the detection of specific intracranial pathology in low

1995 NHS Economic Evaluation Database.

3482. Universal newborn hearing screening: the Colorado story

Universal newborn hearing screening: the Colorado story Universal newborn hearing screening: the Colorado story Universal newborn hearing screening: the Colorado story Downs M P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology (...) Identification of sensorineural or conductive hearing loss in new-born infants. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Newborn infants. Setting Hospital. The location of the economic study was not stated. Dates to which data relate Effectiveness and resourcedata were gathered between 1992 and 1995. Price years were not stated. Source of effectiveness data Derived from a single multi-centre study. Link between effectiveness and cost data Costing

1995 NHS Economic Evaluation Database.

3483. Benefits and costs of screening and treatment for early breast cancer: development of a basic benefit package

Benefits and costs of screening and treatment for early breast cancer: development of a basic benefit package Benefits and costs of screening and treatment for early breast cancer: development of a basic benefit package Benefits and costs of screening and treatment for early breast cancer: development of a basic benefit package Kattlove H, Liberati A, Keeler E, Brook R H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each (...) abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening and treatment strategies for early breast cancer. Type of intervention Screening and treatment. Economic study type Cost-effectiveness analysis. Study population A hypothetical health care organisation with an enrolled population of 500,000, in which 360 new cases of breast cancer would be expected

1995 NHS Economic Evaluation Database.

3484. Prostate cancer screening in a large corporation population

Prostate cancer screening in a large corporation population Prostate cancer screening in a large corporation population Prostate cancer screening in a large corporation population Kantrowitz W, Doyle J, Semeraro J, Krane R J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology Prostate cancer screening. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Male employees of the Polaroid Corporation aged between 50 and 65 years. Setting Occupational. A large public corporation medical department in the United States. Dates to which data relate The start date of the screening programme was unclear. Resources used and costs were presented for the actual programme. The price year

1995 NHS Economic Evaluation Database.

3485. The costs and effects of a nutritional education program following work-site cholesterol screening

The costs and effects of a nutritional education program following work-site cholesterol screening The costs and effects of a nutritional education program following work-site cholesterol screening The costs and effects of a nutritional education program following work-site cholesterol screening Byers T, Mullis R, Anderson J, Dusenbury L, Gorsky R, Kimber C, Krueger K, Kuester S, Mokdad A, Perry G, Smith C A Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Nutritional education program following work-site cholesterol screening. Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis. Study population Employees at 40 small work-sites with serum cholesterol levels of 200mg or more

1995 NHS Economic Evaluation Database.

3486. Declining value of alanine aminotransferase in screening of blood donors to prevent post-transfusion hepatitis B and C virus infection

Declining value of alanine aminotransferase in screening of blood donors to prevent post-transfusion hepatitis B and C virus infection Declining value of alanine aminotransferase in screening of blood donors to prevent post-transfusion hepatitis B and C virus infection Declining value of alanine aminotransferase in screening of blood donors to prevent post-transfusion hepatitis B and C virus infection Busch M P, Korelitz J J, Kleinman S H, Lee S R, Aubuchon J P, Schreiber G B, Williams A E (...) , Ownby H E, Waxman D A, Hutching S, Murphy E L, Gilcher R O, Smith J W, Thomson R A, Nemo G J, Zuck T F Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Alanine aminotransferase (ALT) screening of blood donors. Type of intervention

1995 NHS Economic Evaluation Database.

3487. Mammography screening: an incremental cost effectiveness analysis of two-view versus one-view procedure in London

Mammography screening: an incremental cost effectiveness analysis of two-view versus one-view procedure in London Mammography screening: an incremental cost effectiveness analysis of two-view versus one-view procedure in London Mammography screening: an incremental cost effectiveness analysis of two-view versus one-view procedure in London Bryan S, Brown J, Warren R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each (...) abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Mammography screening by a single view (mediolateral-oblique) and two views (mediolateral-oblique plus craniocaudal) of each breast. Type of intervention Screening Economic study type Cost-effectiveness analysis Study population Women aged between 50 and 64. Setting Primary care/hospital. The economic study

1995 NHS Economic Evaluation Database.

3488. Cost-effectiveness of screening for colorectal cancer: a simulation model

Cost-effectiveness of screening for colorectal cancer: a simulation model Cost-effectiveness of screening for colorectal cancer: a simulation model Cost-effectiveness of screening for colorectal cancer: a simulation model Neilson A R, Whynes D K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology Screening for colorectal cancer using faecal occult blood (FOB) test and/or flexible sigmoidoscopy. Type of intervention Screening. Economic study type Cost-utility analysis. Study population A cohort of hypothetical subjects between 40 and 90 years of age. Setting Hospital. The economic study was carried out in the United Kingdom. Dates to which data relate The data related to the effectiveness analysis were extracted from clinical

1995 NHS Economic Evaluation Database.

3489. MOMs (multiples of the median) and DADs (discriminant aneuploidy detection): improved specificity and cost-effectiveness of biochemical screening for aneuploidy with DADs

MOMs (multiples of the median) and DADs (discriminant aneuploidy detection): improved specificity and cost-effectiveness of biochemical screening for aneuploidy with DADs MOMs (multiples of the median) and DADs (discriminant aneuploidy detection): improved specificity and cost-effectiveness of biochemical screening for aneuploidy with DADs MOMs (multiples of the median) and DADs (discriminant aneuploidy detection): improved specificity and cost-effectiveness of biochemical screening (...) for aneuploidy with DADs Evans M I, Chik L, O'Brien J E, Chin B, Dvorin E, Ayoub M, Krivchenia E L, Ager J W, Johnson M P, Sokol R J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Biochemical screening for Down's Syndrome using single

1995 NHS Economic Evaluation Database.

3490. Development of a practical screening tool to identify preterm, low-birthweight neonates in Ethiopia. (Abstract)

Development of a practical screening tool to identify preterm, low-birthweight neonates in Ethiopia. Preterm, low-birthweight (LBW) newborn infants are at high risk of neonatal mortality and morbidity and need early referral for special paediatric care. In developing countries, birthweight and gestational age often cannot be measured and a practical screening tool based on surrogate neonatal body measurements to identify high-risk infants would be very useful. We studied a consecutive series (...) was 30 cm or less, and were classified as low risk otherwise. When tested in the validation group, this algorithm had sensitivity, specificity, and negative predictive value for prediction of preterm and LBW births above 90%. Thus, neonatal body measurements can be combined into a pragmatic, accurate screening tool suitable for clinical use in developing countries.

1994 Lancet Controlled trial quality: uncertain

3491. Randomised controlled trial of routine cervical examinations in pregnancy. European Community Collaborative Study Group on Prenatal Screening. (Abstract)

Randomised controlled trial of routine cervical examinations in pregnancy. European Community Collaborative Study Group on Prenatal Screening. Preterm delivery is strongly associated with neonatal mortality and morbidity. In some European countries, cervical examinations are used routinely during pregnancy to identify women at risk of preterm delivery. We sought to evaluate the efficacy and secondary effects of these routine cervical examinations. We did a randomised controlled trial in seven

1994 Lancet Controlled trial quality: uncertain

3492. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. Family Heart Study Group. Full Text available with Trip Pro

Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. Family Heart Study Group. To measure the change in cardiovascular risk factors achievable in families over one year by a cardiovascular screening and lifestyle intervention in general practice.Randomised controlled trial in 26 general practices in 13 towns in Britain.12,472 men aged 40-59 and their partners (7460 men and 5012 women) identified (...) factors achieved would mean only a 12% reduction in risk of coronary events.As most general practices are not using such an intensive programme the changes in coronary risk factors achieved by the voluntary health promotion package for primary care are likely to be even smaller. The government's screening policy cannot be justified by these results.

1994 BMJ Controlled trial quality: uncertain

3493. An economic rationale for prostate cancer screening

An economic rationale for prostate cancer screening An economic rationale for prostate cancer screening An economic rationale for prostate cancer screening Benoit R M, Naslund M J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health (...) technology (a) Screening for prostate cancer using prostate-specific antigen(PSA) testing with and without digital rectal examination(DRE) (b) Screening for breast cancer using mammography with and without clinical breast examination. Type of intervention Secondary prevention Economic study type Cost-effectiveness analysis. Study population Men aged 50 to 70 and women aged 50-69. Setting The practice setting for breast cancer screening was not specified (it might be primary care). Prostate cancer

1994 NHS Economic Evaluation Database.

3494. Cost-effectiveness of screening for hereditary hemochromatosis

Cost-effectiveness of screening for hereditary hemochromatosis Cost-effectiveness of screening for hereditary hemochromatosis Cost-effectiveness of screening for hereditary hemochromatosis Phatak P D, Guzman G, Woll J E, Robeson A, Phelps C E Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology Hereditary hemochromatosis screening. Type of intervention Screening, primary prevention. Economic study type Cost-effectiveness analysis. Study population The model assumes a base case of asymptomatic 30-year-old white man. Setting The practice setting was hospital/primary care. The study was carried out in the USA. Dates to which data relate Prices related to 1990. Effectiveness data were mainly derived from studies published between

1994 NHS Economic Evaluation Database.

3495. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne)

Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne) Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne) Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne) Piggott M, Wilkinson P, Bennett J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Measurements of alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotrophin concentrations (Triple test) for prenatal detection of Down's syndrome in second trimester serum samples. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study

1994 NHS Economic Evaluation Database.

3496. The two tier fecal occult blood test: cost-effective screening

The two tier fecal occult blood test: cost-effective screening The two tier fecal occult blood test: cost-effective screening The two tier fecal occult blood test: cost-effective screening Rae A J, Cleator I G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study (...) and the conclusions drawn. Health technology Two-tier fecal occult blood test which is a strategy combining HO Sensa guaiac test and a hemoglobin-specific Hemeselect test when the result of the former is positive. Type of intervention Screening Economic study type Cost-effectiveness analysis Study population The study population included males and females 40 years of age or older. Patients were at high risk, asymptomatic, symptomatic or expressed some personal or family history of gastrointestinal disorders

1994 NHS Economic Evaluation Database.

3497. The costs and benefits of a screening program to detect dementia in older drivers

The costs and benefits of a screening program to detect dementia in older drivers The costs and benefits of a screening program to detect dementia in older drivers The costs and benefits of a screening program to detect dementia in older drivers Retchin S M, Hillner B E Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed (...) critical assessment on the reliability of the study and the conclusions drawn. Health technology Using the Mini-Mental State Examination (MMSE) to screen for dementia in older car drivers. Type of intervention Screening Economic study type cost-effectiveness analysis. Study population A hypothetical cohort of drivers aged 65 and above. Setting A hypothetical non-clinic setting (also relevant to primary care). The economic study was carried out in Virginia, USA. Dates to which data relate

1994 NHS Economic Evaluation Database.

3498. Screening and self examination for breast cancer

Screening and self examination for breast cancer Screening and self examination for breast cancer Screening and self examination for breast cancer Austoker J Authors' objectives To summarise for a primary care audience evidence about the effectiveness of breast screening by mammography and breast self examination. Searching Not stated. This is more a review of reviews: see CRD Comments field. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs (...) , stage at diagnosis, 5 year survival rates, mortality How were decisions on the relevance of primary studies made? The authors do not state how the papers were selected for the review, or how many of the authors performed the selection. Results from "the controversial" Canadian randomised study, which showed an excess mortality among women aged 40-49 years who were offered screening, were excluded without adequate explanation. Assessment of study quality The authors do not report the method used

1994 DARE.

3499. Screening for ovarian cancer

Screening for ovarian cancer Screening for ovarian cancer Screening for ovarian cancer Carlson K J, Skates S J, Singer D E Authors' objectives To critically review the available evidence for screening asymptomatic women for ovarian cancer (OC) with ultrasonography and/or the CA-125 radioimmunoassay. Searching MEDLINE was searched from 1982 for articles published in the English language or with English abstracts. The bibliographies of retrieved articles, and the authors' own files, were also (...) examined. Study selection Study designs of evaluations included in the review No inclusion criteria were specified with respect to study design. Diagnostic performance was assessed using data from case series and randomised trials. Specific interventions included in the review Studies evaluating the CA-125 radioimmunoassay and/or ultrasonography in screening for ovarian cancer were eligible for inclusion. For pelvic examination, studies of transabdominal and transvaginal ultrasound, and the CA-125

1994 DARE.

3500. Screening mammography in women aged 40-49 years: analysis of cost effectiveness

Screening mammography in women aged 40-49 years: analysis of cost effectiveness Screening mammography in women aged 40-49 years: analysis of cost effectiveness Screening mammography in women aged 40-49 years: analysis of cost effectiveness Rosenquist C J, Lindfors K K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed (...) = $6,100. The total costs of a screening programme over 35 (or 45) years were not reported separately, but directly combined with the hypothetical estimated benefits in the synthesised results. Synthesis of costs and benefits Assuming an overall 30% reduction in breast cancer mortality, the incremental cost-effectiveness ratio of annual screening mammography versus observation was $15,500, $35,000 and $26,200 for the age groups 60-69, 80-85 and 40-49 respectively. Since estimates of the reduction

1994 NHS Economic Evaluation Database.